DPPA5

DPPA5 is a eutherian-specific RNA-binding protein containing an atypical KH domain that functions at the intersection of post-transcriptional mRNA regulation, protein stabilization, and stress response in pluripotent stem cells and germ cells. It associates with hundreds of specific mRNA targets including cell-cycle and chromatin regulators, localizes to the nucleus in undifferentiated embryonic stem cells, and redistributes to stress granules under cellular stress (PMID:16872451, PMID:18449859, PMID:28746394). DPPA5 directly binds and stabilizes NANOG protein post-transcriptionally to enhance somatic cell reprogramming to pluripotency, and its protein levels are controlled by FBXO9-mediated ubiquitylation and proteasomal degradation (PMID:26661329, PMID:38227647). In hematopoietic stem cells, DPPA5 suppresses endoplasmic reticulum stress and apoptosis to maintain long-term reconstitution capacity, yet genetic knockout in mice reveals that it is dispensable for ES cell self-renewal and fertility under normal conditions (PMID:24882002, PMID:16504174).

1. 1994 High

   Establishing that DPPA5 transcription is under stringent developmental control resolved how its expression is restricted to pluripotent cells, identifying stem cell-specific promoter/enhancer elements.

   Evidence Nuclear run-on assays and luciferase reporter constructs in F9 embryonal carcinoma cells

   PMID:8123591

   Open questions at the time

   • Identity of the transcription factors driving stem cell-specific expression was not determined
   • Enhancer elements were not mapped at high resolution
2. 2006 High

   Genetic knockout demonstrated that despite its tight pluripotency-associated expression, DPPA5 is dispensable for ES cell self-renewal, normal development, and fertility, raising the question of its specific functional contribution.

   Evidence Homologous recombination knockout in mice and ES cells with phenotypic analysis of viability, fertility, and differentiation

   PMID:16504174

   Open questions at the time

   • Potential redundancy with KHDC1/ECAT1/OOEP family members was not tested
   • Stress or challenge conditions were not examined in KO animals
3. 2006 High

   Identification of DPPA5 as an RNA-binding protein with ~900 mRNA targets established its molecular activity, shifting understanding from a mere pluripotency marker to a post-transcriptional regulator.

   Evidence RNA immunoprecipitation followed by microarray and RT-PCR validation of 20 specific targets

   PMID:16872451

   Open questions at the time

   • Direct RNA-binding specificity and whether the KH domain is necessary for target recognition were not shown
   • Functional consequences of target mRNA binding (stabilization, translational control) were not determined
4. 2006 Medium

   Promoter CpG island methylation was linked to DPPA5 silencing during differentiation, providing an epigenetic mechanism for its developmental regulation.

   Evidence Bisulfite sequencing and RT-PCR in differentiating human ESC lines

   PMID:16479162

   Open questions at the time

   • Causal relationship between methylation and silencing was not established by demethylation experiments
   • Variation between hESC lines was not mechanistically explained
5. 2007 Medium

   Phylogenomic analysis placed DPPA5 within a eutherian-specific KHDC1/DPPA5/ECAT1/OOEP gene family sharing an atypical KH domain, framing its evolutionary origin and potential functional redundancy.

   Evidence Phylogenomic and domain analysis across eutherian genomes

   PMID:17913455

   Open questions at the time

   • Functional equivalence or redundancy among family members was not experimentally tested
   • No structural data for the atypical KH domain
6. 2008 Medium

   Detection of DPPA5 in the nuclear proteome of ESCs, including two isoforms distinguished by N-terminal acetylation, established its subnuclear localization and post-translational modification.

   Evidence Subcellular fractionation, 2-D gel electrophoresis, MALDI-TOF-MS and nano-LC-MS/MS in mouse ESCs and EGCs

   PMID:18449859

   Open questions at the time

   • Functional significance of N-terminal acetylation was not tested
   • Whether nuclear localization is required for RNA-binding function was not addressed
7. 2014 High

   Bidirectional manipulation of DPPA5 in hematopoietic stem cells revealed a non-pluripotency function: suppressing ER stress and apoptosis to maintain long-term reconstitution capacity, explaining the gene's role under physiological challenge.

   Evidence Ectopic overexpression and shRNA knockdown followed by bone marrow transplantation reconstitution assays and ER stress marker analysis

   PMID:24882002

   Open questions at the time

   • Molecular mechanism by which DPPA5 suppresses ER stress is unknown
   • Whether this function depends on its RNA-binding activity was not tested
8. 2015 High

   Demonstration that DPPA5 directly binds and stabilizes NANOG protein post-transcriptionally connected DPPA5 to the core pluripotency network and explained how it enhances iPSC reprogramming.

   Evidence Co-immunoprecipitation, protein stability assays, qRT-PCR, and iPSC reprogramming efficiency assay in human cells

   PMID:26661329

   Open questions at the time

   • The domain of DPPA5 mediating NANOG interaction was not mapped
   • Mechanism of protein stabilization (e.g., blocking specific degradation pathway) was not identified
9. 2017 Medium

   Localization of DPPA5 to stress granules under arsenite or heat shock stress revealed a dynamic subcellular redistribution, suggesting a role in translational regulation during the stress response in iPSCs.

   Evidence Immunofluorescence co-localization with SG markers (G3BP, TIAR, eIF4E, eIF3B, PABP) in human iPSCs

   PMID:28746394

   Open questions at the time

   • Whether DPPA5 is required for stress granule assembly or function was not tested
   • Connection between stress granule localization and mRNA target regulation was not established
10. 2024 Medium

    Identification of FBXO9 as the E3 ubiquitin ligase targeting DPPA5 for proteasomal degradation revealed how DPPA5 protein levels are controlled, with FBXO9 silencing enhancing reprogramming by stabilizing DPPA5.

    Evidence RNAi screen during reprogramming, proteasomal degradation assay, and ubiquitylation assay

    PMID:38227647

    Open questions at the time

    • Specific ubiquitylation sites on DPPA5 were not identified
    • Whether FBXO9-mediated degradation operates in vivo during development was not shown
    • Relationship between FBXO9 regulation and DPPA5-NANOG stabilization axis is unexplored

• The molecular mechanism by which DPPA5's KH domain engages RNA targets and how its RNA-binding versus protein-stabilization (NANOG) functions are coordinated remain unresolved.
• No structure of the atypical KH domain or RNA-binding specificity determinants
• Whether RNA-binding and NANOG stabilization functions are separable or interdependent is unknown
• Functional redundancy with KHDC1/ECAT1/OOEP family members has not been tested genetically